134 related articles for article (PubMed ID: 22184557)
1. Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent.
Kachko L; Ben Ami S; Liberman A; Birk E; Kronenberg S
Pain Res Manag; 2011; 16(6):457-9. PubMed ID: 22184557
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
Meighen KG
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):121-7. PubMed ID: 17343560
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine for childhood depression with pain and dissociative symptoms.
Desarkar P; Das A; Sinha VK
Eur Child Adolesc Psychiatry; 2006 Dec; 15(8):496-9. PubMed ID: 16732464
[TBL] [Abstract][Full Text] [Related]
5. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine.
Marangell LB; Clauw DJ; Choy E; Wang F; Shoemaker S; Bradley L; Mease P; Wohlreich MM
Pain; 2011 Jan; 152(1):31-37. PubMed ID: 20598442
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
Chappell AS; Ossanna MJ; Liu-Seifert H; Iyengar S; Skljarevski V; Li LC; Bennett RM; Collins H
Pain; 2009 Dec; 146(3):253-260. PubMed ID: 19625125
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine (Cymbalta) for diabetic neuropathic pain.
Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
García-Campayo J; Serrano-Blanco A; Rodero B; Magallón R; Alda M; Andrés E; Luciano JV; del Hoyo YL
Trials; 2009 Apr; 10():24. PubMed ID: 19389246
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
Sultan A; Gaskell H; Derry S; Moore RA
BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
Wohlreich MM; Watkin JG; Gonzales JS
J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
[No Abstract] [Full Text] [Related]
15. Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
Schneider E; Linden M; Weigmann H; Wagner T; Quail D; Hundemer HP; Hegerl U
BMC Psychiatry; 2011 Sep; 11():150. PubMed ID: 21933428
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
[TBL] [Abstract][Full Text] [Related]
17. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
20. Diabetic peripheral neuropathic pain: recognition and management.
Cole BE
Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
